Literature DB >> 1544149

Metabolism of food-derived heterocyclic amines in human and rabbit tissues by P4503A proteins in the presence of flavonoids.

R A McKinnon1, W M Burgess, P M Hall, Z Abdul-Aziz, M E McManus.   

Abstract

The ability of human and rabbit gastrointestinal-tract microsomes to metabolize the heterocyclic amine 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ) to a mutagen was determined with the Ames test. When human jejunal and ileal microsomes were used as the metabolic activation source, MeIQ produced 1675 and 388 revertants/mg of microsomal protein, respectively, and this increased to 29,230 and 17,963 revertants/mg of microsomal protein, respectively, in the presence of 100 microM alpha-naphthoflavone. MeIQ in the presence of control rabbit duodenal, jejunal, and ileal microsomes produced 2304 +/- 1018, 988 +/- 386, and 444 +/- 134 (mean +/- SD, four samples) revertants/mg of microsomal protein, respectively. In the presence of alpha-naphthoflavone (100 microM), these activities increased greater than 7-fold. P4503A proteins were detectable on Western blots of microsomes prepared from both human and rabbit small intestine. Further, rifampicin-induced rabbit hepatic-microsomal activation of MeIQ was completely inhibited at low concentrations of alpha-naphthoflavone, but at higher concentrations (i.e., 100 microM) this returned to control levels. Flavone also caused a marked stimulation of MeIQ activation in human and rabbit gastrointestinal-tract microsomes. The aforementioned data suggest that flavonoids markedly increase the ability of P4503A isozymes to activate heterocyclic amines to mutagens in the Ames test.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1544149

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  3 in total

1.  Enterocytic CYP3A4 in a paediatric population: developmental changes and the effect of coeliac disease and cystic fibrosis.

Authors:  T N Johnson; M S Tanner; C J Taylor; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  2001-05       Impact factor: 4.335

2.  Characterisation of CYP3A gene subfamily expression in human gastrointestinal tissues.

Authors:  R A McKinnon; W M Burgess; P M Hall; S J Roberts-Thomson; F J Gonzalez; M E McManus
Journal:  Gut       Date:  1995-02       Impact factor: 23.059

3.  Enhanced expression of cytochrome P450 in stomach cancer.

Authors:  G I Murray; M C Taylor; M D Burke; W T Melvin
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.